We've found
33,560
archived clinical trials in
Neurology
We've found
33,560
archived clinical trials in
Neurology
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
Updated: 10/17/2016
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
Updated: 10/17/2016
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
Updated: 10/17/2016
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
Updated: 10/17/2016
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
Updated: 10/17/2016
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
Updated: 10/17/2016
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
Updated: 10/17/2016
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
Updated: 10/17/2016
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
Updated: 10/17/2016
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
Updated: 10/17/2016
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
Updated: 10/17/2016
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
Updated: 10/17/2016
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
Updated: 10/17/2016
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
Updated: 10/17/2016
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
Updated: 10/17/2016
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
Updated: 10/17/2016
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
Updated: 10/17/2016
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
Updated: 10/17/2016
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
Updated: 10/17/2016
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
Updated: 10/17/2016
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
Click here to add this to my saved trials
Brain Training to Enhance Frontal Lobe Reasoning
Updated: 10/24/2016
Brain Training to Enhance Frontal Lobe Reasoning in Soldiers and Civilian Adults With TBI
Status: Enrolling
Updated: 10/24/2016
Brain Training to Enhance Frontal Lobe Reasoning
Updated: 10/24/2016
Brain Training to Enhance Frontal Lobe Reasoning in Soldiers and Civilian Adults With TBI
Status: Enrolling
Updated: 10/24/2016
Click here to add this to my saved trials
On Track: Monitoring Development of Children With Cerebral Palsy or Gross Motor Delay
Updated: 10/25/2016
Developmental Trajectories of Impairments, Health, and Participation of Children With Cerebral Palsy
Status: Enrolling
Updated: 10/25/2016
On Track: Monitoring Development of Children With Cerebral Palsy or Gross Motor Delay
Updated: 10/25/2016
Developmental Trajectories of Impairments, Health, and Participation of Children With Cerebral Palsy
Status: Enrolling
Updated: 10/25/2016
Click here to add this to my saved trials
On Track: Monitoring Development of Children With Cerebral Palsy or Gross Motor Delay
Updated: 10/25/2016
Developmental Trajectories of Impairments, Health, and Participation of Children With Cerebral Palsy
Status: Enrolling
Updated: 10/25/2016
On Track: Monitoring Development of Children With Cerebral Palsy or Gross Motor Delay
Updated: 10/25/2016
Developmental Trajectories of Impairments, Health, and Participation of Children With Cerebral Palsy
Status: Enrolling
Updated: 10/25/2016
Click here to add this to my saved trials
On Track: Monitoring Development of Children With Cerebral Palsy or Gross Motor Delay
Updated: 10/25/2016
Developmental Trajectories of Impairments, Health, and Participation of Children With Cerebral Palsy
Status: Enrolling
Updated: 10/25/2016
On Track: Monitoring Development of Children With Cerebral Palsy or Gross Motor Delay
Updated: 10/25/2016
Developmental Trajectories of Impairments, Health, and Participation of Children With Cerebral Palsy
Status: Enrolling
Updated: 10/25/2016
Click here to add this to my saved trials
On Track: Monitoring Development of Children With Cerebral Palsy or Gross Motor Delay
Updated: 10/25/2016
Developmental Trajectories of Impairments, Health, and Participation of Children With Cerebral Palsy
Status: Enrolling
Updated: 10/25/2016
On Track: Monitoring Development of Children With Cerebral Palsy or Gross Motor Delay
Updated: 10/25/2016
Developmental Trajectories of Impairments, Health, and Participation of Children With Cerebral Palsy
Status: Enrolling
Updated: 10/25/2016
Click here to add this to my saved trials
On Track: Monitoring Development of Children With Cerebral Palsy or Gross Motor Delay
Updated: 10/25/2016
Developmental Trajectories of Impairments, Health, and Participation of Children With Cerebral Palsy
Status: Enrolling
Updated: 10/25/2016
On Track: Monitoring Development of Children With Cerebral Palsy or Gross Motor Delay
Updated: 10/25/2016
Developmental Trajectories of Impairments, Health, and Participation of Children With Cerebral Palsy
Status: Enrolling
Updated: 10/25/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Updated: 10/27/2016
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
Click here to add this to my saved trials